Reorganization Strategy to Optimize the Use of Virtual Reality
Condition(s) studied
Investigational drug(s) / intervention(s)
Semi-structured interviews: Patients and caregivers will be interviewed about the barriers and facilitators to the use of VR masks in the management of pain and anxiety, in order to propose organizational changes that encourage their use.
Study summary
The benefits of virtual reality (VR) in managing pain and anxiety for critical care patients has never been demonstrated, even if a positive effect has been demonstrated in other populations of patients. A preliminary survey in 8 critical care units equipped with the VR mask, identified a under-use of masks by critical care teams. Before addressing the question of the effectiveness of the VR mask in a population of critical care patients, we must first identify the barriers and facilitators to its use and propose a new organization in critical care units promoting the use of VR mask by autonomous caregivers. A qualitative study will be conducted with patients and caregivers of a critical care unit to identify the barriers and facilitators to the use of virtual reality masks in the management of pain and anxiety by caregivers.
Eligibility
Primary outcome measure(s)
- Identify the barriers and facilitators to the use of virtual reality mask by paramedical staff in the management of invasive care for critical care patients — Participants will be interviewed once (about one-hour interview)
Patients and caregivers of a cardiac critical care unit will be interviewed (semi-structured interviews) to gather their perceptions on the use of virtual reality mask for pain and anxiety management in invasive care for critical care patients
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Louis Pradel - Hospices Civils de Lyon | Bron | France |
More Hospices Civils de Lyon trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07132710 on ClinicalTrials.gov ↗ ← All trials in France